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Fat and carbohydrate are the principal substrates that fuel
aerobic ATP synthesis in skeletal muscle. Endogenous
carbohydrates, mainly stored as muscle and liver glycogen,
represent less than 5 % of total energy storage in an average
man. The vast majority of our energy reserves is stored as
fat, mainly deposited as triacylglycerol (TG) in
subcutaneous and deep visceral adipose tissue. Smaller
quantities of TG are present in circulating lipoprotein
particles and in lipid droplets inside the muscle fibres,
intramyocellular triacylglycerol (IMTG; Hoppeler et al.
1985). The latter has recently regained much attention due
to the proposed functional relationship between IMTG
accumulation and the development of insulin resistance
(Boden et al. 2001). It is speculated that elevated free fatty
acid (FFA) delivery and/or impaired FA oxidation result in
intramyocellular accumulation of TG and FA metabolites,
which could induce defects in the insulin signalling
cascade, causing skeletal muscle insulin resistance. The
progressive accumulation of IMTG in sedentary, obese
and/or type 2 diabetes patients should therefore form a
major therapeutic target and efforts should be made to
develop interventions that prevent excess IMTG accretion
by stimulating their rate of oxidation. However, the latter
is complicated by the fact that information on the
regulation of IMTG metabolism is scarce.
Several studies applying FA isotope tracers have shown
that during moderate intensity exercise ~40–60 % of total
fat oxidation is accounted for by plasma derived FFA
oxidation in endurance trained male subjects following an
overnight fast (Romijn et al. 1993; Sidossis et al. 1998;
Coyle et al. 2001; van Loon et al. 2001). This implies that
other fat sources can contribute substantially to total fat
oxidation during exercise. However, the relative
contribution of these other fat sources to energy
expenditure has been shown to depend on exercise
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Both stable isotope methodology and fluorescence microscopy were applied to define the use of
intramuscular triglyceride (IMTG) stores as a substrate source during exercise on a whole-body as
well as on a fibre type-specific intramyocellular level in trained male cyclists. Following an overnight
fast, eight subjects were studied at rest, during 120 min of moderate intensity exercise (60 %
maximal oxygen uptake capacity (◊J,max)) and 120 min of post-exercise recovery. Continuous
infusions of [U-13C]palmitate and [6,6–2H2]glucose were administered at rest and during
subsequent exercise to quantify whole-body plasma free fatty acid (FFA) and glucose oxidation
rates and the contribution of other fat sources (sum of muscle- plus lipoprotein-derived TG) and
muscle glycogen to total energy expenditure. Fibre type-specific intramyocellular lipid content was
determined in muscle biopsy samples collected before, immediately after and 2 h after exercise. At
rest, fat oxidation provided 66 ± 5 % of total energy expenditure, with FFA and other fat sources
contributing 48 ± 6 and 17 ± 3 %, respectively. FFA oxidation rates increased during exercise, and
correlated well with the change in plasma FFA concentrations. Both the use of other fat sources and
muscle glycogen declined with the duration of exercise, whereas plasma glucose production and
utilisation increased (P < 0.001). On average, FFA, other fat sources, plasma glucose and muscle
glycogen contributed 28 ± 3, 15 ± 2, 12 ± 1 and 45 ± 4 % to total energy expenditure during
exercise, respectively. Fluorescence microscopy revealed a 62 ± 7 % net decline in muscle lipid
content following exercise in the type I fibres only, with no subsequent change during recovery. We
conclude that IMTG stores form an important substrate source during moderate intensity exercise
in endurance-trained male athletes following an overnight fast, with the oxidation rate of muscle-
plus lipoprotein-derived TG being decreased with the duration of exercise.
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intensity (Romijn et al. 1993; van Loon et al. 2001),
exercise duration (Romijn et al. 1993), training status
(Martin et al. 1993; Phillips et al. 1996a; Sidossis et al. 1998;
Schrauwen et al. 2002) and diet (Schrauwen et al. 2000;
Coyle et al. 2001) and is much lower in obese and/or type 2
diabetes patients (Blaak et al. 2000; Borghouts et al. 2002)
compared with trained subjects. It is generally assumed
that both muscle- and lipoprotein-derived TG contribute
to the oxidation rate of these other fat sources (Havel et al.
1967; Oscai et al. 1990; Frayn et al. 1996). Though the
oxidation rate of IMTG plus lipoprotein-derived TG
appears to be most pronounced in highly trained
endurance athletes exercising at a moderate intensity
workload following an overnight fast (van Loon et al.
2001), recent findings indicate that only 3 months of low-
intensity endurance training are needed to achieve a 2- to
3-fold increase in the capacity of sedentary subjects to use
these TG sources during moderate intensity exercise
(Schrauwen et al. 2002).
Not all expert laboratories agree with the contention that
IMTG stores are oxidised during exercise (Watt et al.
2002b). For example, studies applying direct muscle TG
extraction analysis on muscle samples collected before and
after moderate intensity exercise in both trained and
untrained subjects have provided contradictory findings
(Watt et al. 2002b). For example, it has recently been
suggested that IMTG stores do not play a significant role
during moderate intensity exercise in trained men as
opposed to trained women (Roepstorff et al. 2002;
Steffensen et al. 2002), but rather form an important
substrate source during post-exercise recovery (Kiens &
Richter, 1998). Watt et al. (2002b) suggested that the
apparent discrepancy between the many published studies
is largely due to the high between biopsy variability when
using the muscle TG extraction technique to estimate net
IMTG use. The latter could probably be explained by the
presence of extramyocellular fat and/or differences in
fibre-type composition in the obtained muscle samples.
Studies using magnetic resonance spectroscopy (MRS) to
quantify both intra- and extramyocellular lipid content all
support the contention that substantial net decreases in
intramyocellular TG content (~20–40 %) occur following
prolonged endurance exercise in both trained men and
women (Boesch et al. 1997, 1999; Krssak et al. 2000; Rico-
Sanz et al. 2000; Brechtel et al. 2001; Decombaz et al. 2001;
Larson-Meyer et al. 2002; van Loon et al. 2003b).
None of the techniques mentioned so far discriminate
between muscle fibre type-specific IMTG content. The
latter could be of importance as muscle fibre-type
recruitment during endurance-type exercise tasks mainly
relies on the use of type I muscle fibres (Hultman, 1995),
which have been shown to contain ~3- to 4-fold more lipid
than type II fibres (Essen et al. 1975; Malenfant et al. 2001).
Therefore, we hypothesised that any net decreases in
muscle TG content after prolonged moderate intensity
exercise would be more pronounced in type I versus type II
muscle fibres. To enable a direct and selective
quantification of muscle TG content on a fibre type-
specific intramyocellular level, we recently optimised the
combined use of oil red O staining of muscle cross-
sections with (immuno)fluorescence microscopy
(Koopman et al. 2001).
Due to the apparent discrepancy in the existing literature
on the capacity of human skeletal muscle to oxidise IMTG
we investigated a number of novel aspects on the role of
IMTG as a substrate source during moderate intensity
exercise (~60 % ◊J,max) in endurance-trained male cyclists
following an overnight fast. These conditions were selected
as they most probably lead to the highest absolute total fat
and/or IMTG oxidation rates, and as such provide the best
opportunity to determine whether IMTG stores can be
used as a substrate source during exercise. Our main aim
was to determine whether fibre type-specific changes in
muscle lipid content occur following prolonged
endurance exercise and/or short-term recovery. The latter
was performed by applying fluorescence microscopy on oil
red O-stained muscle cross-sections, prepared from
biopsy samples taken before, immediately after and 2 h
after exercise. Simultaneously, using stable isotope tracer
methodology, we investigated the time course of the
contribution of muscle- plus lipoprotein-derived TG
oxidation to whole-body energy expenditure during the
entire 2 h exercise trial.
METHODS 
Subjects
Eight male cyclists (age: 22.8 ± 0.8 years; height: 1.85 ± 0.03 m;
body weight: 76.5 ± 3.8 kg; fat-free mass: 66.1 ± 2.7 kg; maximal
power output (Wmax): 391 ± 14 W; and maximal oxygen uptake
capacity (◊J,max): 60.5 ± 2.3 ml (kg body weight)_1 min_1) were
selected to participate in this study. Subjects were informed about
the nature and risks of the experimental procedures before their
written informed consent was obtained. This study was approved
by the medical ethical committee of the Maastricht Academic
Hospital (AZM) and it conforms to the standards set by the
Declaration of Helsinki.
Pre-testing
Wmax and ◊J,max were measured on an electronically braked cycle
ergometer (Lode Excalibur, Groningen, The Netherlands) during
an incremental exhaustive exercise test (Kuipers et al. 1985)
1 week before the first experimental trial. Body composition was
assessed using the hydrostatic weighing method in the morning
after an overnight fast. Simultaneously, residual lung volume was
measured by the helium-dilution technique using a spirometer
(Volugraph 2000, Mijnhardt, Bunnik, The Netherlands). Body
weight was measured with a digital balance with an accuracy of
0.001 kg (E1200, August Sauter GmbH, Albstadt, Germany).
Body fat percentage was calculated using Siri’s equation (Siri,
1956). Fat-free mass (FFM) was calculated by subtracting fat mass
(FM) from total body weight.
L. J. C. van Loon and others612 J Physiol 553.2
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Diet and activity prior to testing
All subjects were instructed to refrain from heavy physical labour
and exercise training for at least 3 days prior to each trial. They
were also instructed to fill out a food intake diary for 2 days prior
to the first exercise trial to keep their dietary intake as identical as
possible prior to the other trial. The evening before each trial,
subjects received the same standardised meal (41.2 kJ
(kg body weight)_1; consisting of 72 Energy % (En %)
carbohydrate, 11 En % fat and 17 En % protein).
Experimental trials
Each subject performed two similar trials, separated by at least
1 week. Each trial consisted of 90 min of resting measurements,
followed by 120 min of cycling exercise (50 % Wmax) and a
subsequent 120 min recovery period. In the main trial, a [U-13C]
palmitate and [6,6-2H2]glucose tracer were infused continuously
at rest and during exercise with breath, blood and muscle samples
collected to quantify the use of different substrate sources and to
determine changes in intramyocellular lipid content. The other
trial was performed to determine the acetate recovery factor to
correct [U-13C]palmitate oxidation rates for the loss of label by
way of isotopic exchange reactions in the TCA cycle (Sidossis et al.
1995; van Loon et al. 2003a). During this trial a [1,2-13C]acetate
tracer was infused continuously at rest and during exercise and
only breath samples were collected.
Protocol
After an overnight fast, subjects arrived at the laboratory at 08.00 h
by car or public transportation. After 30 min of supine rest, a
percutaneous muscle biopsy sample (Bergstrom, 1975) was taken
from the vastus lateralis muscle. A Teflon catheter (Baxter BV,
Utrecht, The Netherlands) was inserted into an antecubital vein of
one arm for blood sampling and another catheter was inserted in
the contralateral arm for isotope infusion. Thereafter, a resting
blood sample was taken and an expired breath sample was collected
into a vacutainer tube (Becton Dickinson, France). Subsequently,
subjects were administered a single intravenous dose of NaH13CO3
(0.06375 mg kg_1), to prime the bicarbonate pool(s), followed by a
[6,6-2H2]glucose prime (13.5 mmol kg_1). Thereafter, a continuous
infusion of [6,6-2H2]glucose (0.3 mmol kg_1 min_1) and [U-
13C]palmitate (0.01 mmol kg_1 min_1) (or [1,2-13C]acetate in the
acetate recovery trial) was started (t = 0) via a calibrated IVAC
pump (IVAC 560, San Diego, CA, USA) and continued for 210 min
until cessation of exercise. At t = 90 min subjects started to exercise
on a cycle ergometer at a workload of 50 % Wmax for a 2 h period.
Whilst at rest, oxygen uptake (◊J) and carbon dioxide production
(◊CJ) were measured continuously (Oxycon-b, Mijnhardt, The
Netherlands). During exercise, ◊Jand ◊CJwere measured for 5 min
every 15 min before sampling of blood and expired breath.
Immediately after cessation of exercise, a second muscle biopsy
sample was taken, after which subjects rested supine for 2 h during
which ◊J and ◊CJ were measured continuously. After 2 h of post-
exercise recovery a third muscle biopsy sample was taken. Muscle
biopsy samples were collected from both legs. The first two biopsy
samples were taken from the same incision in one leg, the third was
collected from another incision in the contralateral leg. When
biopsy samples were taken from the same incision, the first sample
was taken from different fibres (distal of the incision, with the
needle pointing inwards) than the second (proximal with the needle
pointing outwards). Breath and blood samples were collected at
t = 0, 30, 60, 75 and 90 min (at rest) and at t = 105, 120, 135, 150,
165, 180, 195 and 210 min (during exercise). In addition, blood
samples were collected at t = 225, 240, 270, 300, 315 and 330 min
(during post-exercise recovery).
Tracer infusion
Stable isotope tracers were infused at rest, before onset of exercise,
and continued until cessation of exercise. Infusion rates of
[U-13C]palmitate and [6,6-2H2]glucose averaged 8.8 ± 0.2 and
281.3± 8.9 nmol kg_1 min_1, respectively. At the onset of exercise
[U-13C]palmitate infusion rates were doubled (17.6 ± 0.4 nmol
kg_1 min_1). In the acetate recovery trial, a corresponding amount
of 13C was infused, resulting in average [1,2-13C]acetate infusion
rates of 70.3 ± 2.0 and 139.9 ± 3.9 nmol kg_1 min_1 at rest and
during exercise, respectively. The palmitate tracer (99 % enriched,
Cambridge Isotope Laboratories, Andover, MA, USA) was
dissolved in heated sterile water and passed through a 0.2 mm filter
into 5 % warm human serum albumin to make a 1.00 mM solution.
Both the glucose and acetate tracer (99 % enriched, Cambridge
Isotope Laboratories) were dissolved in 0.9 % saline. Palmitate,
glucose and acetate tracer concentrations in the infusates averaged
1.00 ± 0.02, 22.1 ± 0.9 and 4.58 ± 0.13 mmol l_1, respectively.
Blood and breath sample analysis
Blood samples (7 ml) were collected in EDTA-containing tubes
and centrifuged at 1000 g at +4 °C for 10 min. Aliquots of plasma
were frozen immediately in liquid nitrogen and stored at _80 °C.
Plasma glucose (Uni Kit III, Roche, Basel, Switzerland), lactate
(Gutmann & Wahlefeld, 1974), FFA (Wako NEFA-C test kit,
Wako Chemicals, Neuss, Germany), glycerol (148270, Roche
Diagnostics, Indianapolis, IN, USA) and triglyceride (GPO-
trinder 337B, Sigma Diagnostics, St Louis, MO, USA)
concentrations were analysed with a COBAS FARA semi-
automatic analyser (Roche).
For determination of plasma palmitate concentration and
enrichment, palmitate was first extracted from plasma. Briefly,
heptadecanoic acid (100 ml) was added to 400 ml of plasma after
which samples were deproteinised by adding 3.7 ml methanol.
After centrifugation, lipids were extracted by adding 3.9 ml
chloroform and 1.7 ml saline (17 mM). After centrifugation the
chloroform fraction was collected. A second extraction was
performed on the water fraction, by adding 2 ml
chloroform/methanol/water (85:14:1). After centrifugation, both
chloroform fractions were combined and evaporated under N2.
The different lipid classes were isolated by thin-layer
chromatography (TLC). The evaporated chloroform fractions
were dissolved in 100 ml chloroform/methanol (1:1), transferred
onto the TLC plates (113894, Merck, Germany), developed in
chloroform/ methanol/acetic acid/water (100:100:10:10) and,
after drying (N2 at 50 °C), in petroleum benzine/diethyl
ether/acetic acid (120:25:1.5). After development of the plates the
FFA band was isolated. Following the addition of 2 ml
methanol/iso-octane (4:1) and 0.2 ml acetylchloride, the mixture
was incubated for 1 h at 100 °C. Thereafter, the methylesters were
extracted by adding 5 ml of 6 % potassium carbonate. After
mixing and centrifugation, the iso-octane fraction was evaporated
under N2, re-dissolved in 25 ml iso-octane and measured on an
analytical gas chromatograph (GC; Autosystem XL, Perkin Elmer,
USA) with flame ionisation detection using heptadecanoic acid as
an internal standard. The palmitate concentration was
determined by injecting 2 ml in the split mode (1/20), onto a 50 m
Chrompack capillary column (cp-sil88 tailor FAME made, i.d.
0.25 mm, 2 mm film thickness; Varian), injector and detector
temperature at 300 °C, with helium carrier gas at 130 kPa. The
instrument was controlled and the palmitate concentration
automatically calculated from palmitic and heptadecanoic acid
standard curves. Plasma palmitate comprised on average
25.2 ± 0.6 % of total FFA. Isotope tracer/tracee ratio (TTR) of
IMTG use during exerciseJ Physiol 553.2 613
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[U-13C]palmitate was determined using GC-combustion-isotope
ratio mass spectrometry (GC-C-IRMS; Varian-Finnigan GC
combustion II, Finnigan MAT 252, Bremen, Germany). The
palmitate enrichment was determined by 2 ml split injection on a
25 m capillary fused-silica column (Ultra1, HP, USA) with a
splitflow of 30 ml min_1. The methyl derivative of palmitate
contains 17 carbons of which 16 are palmitate, and thus the TTR
of palmitate was corrected by a factor 17/16. Plasma glucose was
first extracted with chloroform–methanol–water and
derivatisation was performed with butylboronic acid and acetic
anhydride as described previously (Pickert et al. 1991). Following
derivatisation, plasma [6,6-2H2]glucose enrichment was
determined by electron ionisation GC-MS (Finnigan INCOS-
XL). Both glucose (Uni Kit III, 0736724, Roche) and acetate (Kit
148261, Boehringer) concentrations in the infusates were
determined with the COBAS FARA semi-automatic analyser.
Calculations
From respiratory measurements, total fat and carbohydrate
oxidation rates were calculated using the non-protein respiratory
quotient (Peronnet & Massicotte, 1991).
Fat oxidation rate = 1.695◊J _ 1.701◊CJ. (1)
Carbohydrate oxidation rate = 4.585◊CJ _ 3.226◊J. (2)
◊J and ◊CJ are measured in l min_1 and oxidation rates are
measured in g min_1. Breath and plasma enrichments are
expressed as tracer/tracee ratios (TTR):
TTR = (13C/12C)Sa _ (
13C/12C)Bk, (3)
where Sa indicates sample and Bk indicates background value. As
plasma glucose and palmitate concentrations and/or enrichments
gradually changed over time (Figs 2A and 6), non-steady-state
Steele equations (Steele, 1959) were applied to calculate tracer
kinetics. Rate of appearance (Ra) and rate of disappearance (Rd) of
palmitate and glucose were calculated using the single-pool Steele
equations adapted for stable isotope methodology as described
elsewhere (Wolfe & Jahoor, 1990).
F _ V((C2 + C1)/2)((E2 _ E1)/(t2 _ t1))Ra = ———————————————, (4)(E2 + E1)/2
Rd = Ra _ V((C2 _ C1)/(t2 _ t1)), (5)
where F is the infusion rate (in mmol kg_1 min_1); V is the
distribution volume for palmitate or glucose (40 and 160 ml kg_1,
respectively); C1 and C2 are the palmitate or glucose
concentrations (in mmol l_1) at time 1 (t1) and time 2 (t2),
respectively, and E2 and E1 are the plasma palmitate or glucose
enrichments (TTR) at times 1 and 2, respectively. The rate of
13CO2 production (Pr
13CO2; measured in mol min
_1) from the
infused palmitate tracer was calculated as:
Pr13CO2 = (TTRCJ◊CJ)/(kAr), (6)
where TTRCJ is the breath 13C/12C ratio at a given time point, ◊CJ
is the rate of carbon dioxide production (in l min_1), k is the
volume of 1 mol CO2 (22.4 l mol
_1); and Ar is the fractional 13C
label recovery in breath CO2, observed after the infusion of
labelled acetate (Sidossis et al. 1995; Schrauwen et al. 1998; van
Loon et al. 2003a) and calculated as:
Ar = ((TTRCJ◊CJ)/(k2F)), (7)
where F is the infusion rate of [1,2-13C] acetate (in mol min_1).
The rate of plasma palmitate oxidation (Rox) (in mol min
_1) can
subsequently be calculated as:
Rox(palmitate) = Rd(palmitate)(Pr
13CO2/16F), (8)
where Rd(palmitate) is the rate of disappearance of palmitate
(mol min_1); F is the palmitate infusion rate (mol min_1) and 16 is
the number of labelled carbon atoms in palmitate. Total plasma
FFA oxidation was calculated by dividing palmitate oxidation
rates by the fractional contribution of plasma palmitate to total
plasma FFA concentration. The contribution of plasma FFA
oxidation to total fat oxidation was calculated by assuming that
triacylglycerol molecular mass equals 860 g mol_1 and that every
L. J. C. van Loon and others614 J Physiol 553.2
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triacylglycerol molecule contains three fatty acids. The
contribution of fat sources other than plasma FFA was calculated
by subtracting plasma FFA oxidation from total fat oxidation.
In a previous study, where we applied both [U-13C] and
[6,6-2H2]glucose tracers (Jeukendrup et al. 1999) during moderate
intensity exercise, it was shown that the percentage of plasma
glucose Rd that was oxidised was between 96–100 %. Therefore,
plasma glucose oxidation rate during exercise was calculated as:
Rox(plasma glucose) = Rd(plasma glucose). (9)
Whole-body muscle glycogen use was calculated by subtracting
plasma glucose oxidation from total carbohydrate oxidation. As
plasma glucose Rd does not match Rox during resting conditions
(Trimmer et al. 2001), plasma glucose oxidation rates cannot be
accurately calculated at rest when using a [6,6-2H2]glucose tracer.
Muscle sample analysis
Muscle samples were dissected carefully, freed from any visible
non-muscle material, rapidly frozen in liquid nitrogen-cooled
isopentane and embedded in Tissue-Tek (Sakura Finetek,
Zoeterwoude, The Netherlands). Multiple serial sections (5 mm)
from biopsy samples collected before, immediately after and 2 h
after exercise were thaw-mounted together on uncoated, pre-
cleaned glass slides for each subject. To permit quantification of
intramyocellular lipid stained by oil red O together with
immunolabelled cellular constituents we used the protocol as
described by Koopman et al. (2001). Briefly, cryosections were
fixed in 3.7 % formaldehyde for 1 h. Slides were rinsed with
deionised water, treated with 0.5 % Triton X-100 in PBS, and
washed with PBS. Thereafter, sections were incubated with
antibodies against human laminin (polyclonal rabbit antibody,
Sigma Diagnostics, Steinheim, Germany) and human myosin
heavy chain (A4.840), developed by Dr Blau (Cho et al. 1993),
enabling us to visualise individual cell membranes and to
determine muscle fibre-type (I or II), respectively. Incubation was
followed by washes in PBS, after which the appropriate conjugated
antibodies GARIgGAlexa350 and GAMIgMAlexa488 (Molecular
Probes, Leiden, The Netherlands) were applied. After several
washes with PBS, glass slides were immersed in the oil red O
working solution. Oil red O stock solution was prepared by adding
500 mg oil red O (Fluka Chemie, Buchs, Switzerland) to 100 ml
60 % triethylphosphate. Prior to staining, a 36 %
triethylphosphate working solution, containing 12 ml oil red O
stock solution and 8 ml deionised water, was prepared and filtered
to remove crystallised oil red O. After 30 min of oil red O
immersion, slides were rinsed with deionised water followed by a
10 min wash with tap water. Stained sections were embedded in
Mowiol and covered with a coverslip.
After 24 h, glass slides were examined using a Nikon E800
fluorescence microscope (Uvikon, Bunnik, The Netherlands)
coupled to a Basler A113 C progressive scan colour CCD camera,
with a Bayer colour filter. Epifluorescence signal was recorded
IMTG use during exerciseJ Physiol 553.2 615
Figure 1. Immunohistochemistry
Digitally captured images of one single field-of-view (w240 magnification) taken from a muscle cross-section
obtained from a pre-exercise muscle biopsy sample showing the epifluorescence signal as recorded using a
DAPI UV excitation filter for laminin (showing the cell membranes in blue; A), a fluorescein isothiocyanate
(FITC) excitation filter for myosin heavy chains (showing the type I muscle fibres in green; B) and a Texas red
excitation filter for the oil red O signal (showing the intramyocellular lipid droplets in red; C). D, the oil red O
signal obtained in Fig. 1C after applying the intensity threshold (showing the lipid droplets in white), which
was subsequently used for data processing and quantitative analysis.
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using a Texas red excitation filter (540–580 nm) for oil red O, a
fluorescein isothiocyanate (FITC) excitation filter (465–495 nm)
for muscle fibre-type, and a 4‚,6-diamidino-2-phenylindole
(DAPI) UV excitation filter (340–380 nm) for laminin. Digitally
captured images (w240 magnification; Fig. 1), at least five fields-
of-view per muscle cross-section (with an average of 10 ± 0.3
fibres per field-of-view), were processed and analysed using Lucia
6.01 software (Nikon, Düsseldorf, Germany). The oil red O
epifluorescence signal was quantified for each muscle fibre,
resulting in a total of 56 ± 3 muscle fibres analysed for each muscle
cross-section (32 ± 2 type I and 24 ± 2 type II muscle fibres). An
intensity threshold representing minimal intensity values
corresponding to lipid droplets was set manually and uniformly
used for all images. Total area measured and the area as well as the
number of objects emitting oil red O epifluorescence signal were
recorded. Fibre type-specific IMTG content was expressed as the
percentage of the measured area that was stained with oil red O. In
two subjects, two different muscle samples were collected and
analysed; the coefficient of variance averaged 10.5 and 38.6 % for
the type I and type II fibres, respectively. Average lipid droplet size
was calculated by dividing the total area lipid stained by total
number of droplets. Lipid droplet density was calculated by
dividing the total number of droplets by the total area measured.
Statistics
All data are expressed as means ± S.E.M. To compare tracer
kinetics, substrate utilisation rates, IMTG contents and/or plasma
metabolite concentrations over time, a repeated measures analysis
of variance (ANOVA) was applied. A Scheffé post hoc test was
applied in case of a significant F-ratio to locate specific differences.
For non-time-dependent variables, Student’s t test for paired
observations was used. Simple linear regression was used to
investigate specific correlations. Significance was set at the 0.05
level of confidence.
RESULTS
Tracer kinetics
Plasma glucose and palmitate enrichments are shown in
Fig. 2A. Both Ra and Rd of glucose were significantly higher
during exercise compared to pre-exercise resting values
(Table 2 and Fig. 3A), with plasma glucose Ra and Rd
increasing over time during the exercise trial (Fig. 3A;
P < 0.001). Breath 13CO2 enrichments at rest and during
exercise are shown in Fig. 2B. Ra, Rd and Rox of palmitate
were significantly higher during exercise compared to
resting values (Table 2 and Fig. 3B), with plasma palmitate
Ra, Rd and Rox increasing over time during exercise (Fig. 3B;
P < 0.001). Fractional acetate label recovery was
significantly higher during exercise compared to resting
values (Table 2).
Substrate utilisation
Results of the gas exchange measurements are provided in
Table 1. Energy expenditure and average utilisation rates
of the different endogenous substrate sources at rest,
during 2 h of submaximal exercise and during 2 h of post-
exercise recovery are summarised in Table 3. Changes in
substrate utilisation rates over time during exercise are
illustrated in Fig. 4. At rest, fat oxidation rates averaged
0.09 ± 0.01 g min_1, contributing 66 ± 5 % to total energy
expenditure (Table 3). An average of 48 ± 6 % of total
energy expenditure was accounted for by plasma FFA
oxidation, with the use of other fat sources contributing
17 ± 3 %. Carbohydrate oxidation rates averaged
0.12 ± 0.02 g min_1, representing the remaining 34 ± 5 %
of total energy expenditure.
In the subsequent exercise trial, the 50 % Wmax workload
applied represented 196 ± 7 W on average, which
corresponded to 60.1 ± 1.0 % ◊J,max (Table 1). During
exercise, total fat oxidation rates significantly increased
over time, with a concomitant decrease in total
carbohydrate oxidation rates (P < 0.001). The increase in
total fat oxidation rate during exercise was accounted for
by a substantial increase in plasma FFA oxidation rate,
whereas the oxidation rate of other fat sources (muscle-
and lipoprotein-derived TG) was reduced over time
(P < 0.001). The latter decline became most evident
during the second hour of exercise. Calculated over the
entire 2 h exercise period, fat oxidation averaged
0.61 ± 0.06 g min_1 (43 ± 4 % of total energy
expenditure), with plasma FFA oxidation being the main
fat source representing 28 ± 3 % of total energy
expenditure, and the utilisation of other fat sources
contributing the remaining 15 ± 2 %. The decrease in total
carbohydrate oxidation rate during exercise was
accounted for by a substantial decrease in the use of muscle
glycogen, whereas plasma glucose oxidation increased
progressively over time (P < 0.001). Calculated over the
entire 2 h exercise period, carbohydrate oxidation rates
averaged 2.05 ± 0.15 g min_1 (57 ± 4 %), with muscle
glycogen being the main carbohydrate source representing
45 ± 4 % of total energy expenditure and plasma glucose
utilisation contributing 12 ± 1 %.
In the post-exercise recovery period fat oxidation averaged
0.12 ± 0.01 g min_1, which was significantly higher
compared to pre-exercise resting values (P < 0.001).
Concomitantly, carbohydrate oxidation rates averaged
L. J. C. van Loon and others616 J Physiol 553.2
Jo
u
rn
al
 o
f P
hy
si
ol
og
y
0.10 ± 0.02 g min_1, which was significantly lower
compared to pre-exercise resting values (P < 0.001).
Though the increased fat utilisation rate observed in the
recovery period was partly attributed to the higher energy
expenditure during post-exercise recovery compared to
pre-exercise resting values (6.39 ± 0.3 vs. 5.76 ± 0.22 kJ
min_1; P < 0.01), the relative contribution of fat oxidation
to total energy expenditure was also significantly increased
in the post-exercise recovery period (75 ± 5 vs. 66 ± 5 %;
P < 0.001).
Muscle tissue analysis
Muscle tissue analysis for IMTG content using fluorescence
microscopy on oil red O stained muscle cross-sections
showed a substantial 62 ± 7 % decrease in lipid content in
the type I fibres only (P < 0.01), with IMTG content in the
type I muscle fibres being significantly lower both
immediately post-exercise as well as following 2 h of post-
exercise recovery compared to pre-exercise values
(Fig. 5A). The latter was observed in each individual subject
(Fig. 5B). The observed decrease in IMTG content was
accounted for by a significant decrease in both lipid droplet
size (0.74 ± 0.06, 0.49 ± 0.06 and 0.51 ± 0.05 mm2) as well
as lipid droplet density (0.07 ± 0.004, 0.03 ± 0.004 and
0.04 ± 0.007 droplets mm_2) as determined before and
immediately after exercise and after 2 h of post-exercise
recovery, respectively (P < 0.01). In the type II muscle
fibres no significant changes were observed.
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Figure 2. Plasma and breath enrichment data
Plasma [6,6-2H2]glucose and [U-
13C]palmitate enrichment
(expressed in tracer/tracee ratio; TTR) at rest and during exercise
(A) and 13CO2 enrichment in the expired breath (expressed in
TTR) following [U-13C]palmitate infusion and following [1,2-13C]
acetate infusion in the acetate recovery trial (B). Data are
means ± S.E.M.; * significantly different from values at t = 60 or 105
during the resting period and the exercise trial, respectively
(P < 0.05).
Figure 3. Plasma glucose and palmitate kinetics
Plasma glucose rate of appearance (Ra) and disappearance (Rd) (A)
and plasma palmitate Ra, Rd and rate of oxidation (Rox) (B) during
prolonged submaximal endurance cycling exercise (expressed inmmol kg_1 min_1). Plasma glucose Ra and Rd and palmitate Ra, Rd
and Rox substantially increased during exercise (P < 0.001). Data
are means ± S.E.M.; * significantly higher than value at t = 120 min
(P < 0.05).
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Comparisons between muscle fibre types showed
significantly higher IMTG content in the type I compared
to the type II fibres before exercise (Figs 1 and 5), which was
accounted for by a significantly greater lipid droplet size
(0.74 ± 0.06 vs. 0.54 ± 0.06 mm2) as well as a higher lipid
droplet density (0.07 ± 0.004 vs. 0.03 ± 0.004 dropletsmm_2) in the type I vs. type II muscle fibres, respectively.
Immediately after exercise as well as after 2 h of recovery,
lipid content was not different between muscle fibre types
(Fig. 5). In accordance, average lipid droplet size was
similar between muscle fibre types immediately post-
exercise as well as after 2 h of recovery; 0.49 ± 0.06 and
0.51 ± 0.05 vs. 0.51 ± 0.11 and 0.47 ± 0.04, in the type I and
II muscle fibres, respectively. Lipid droplet density
remained significantly higher in the type I compared to the
type II muscle fibres; 0.03 ± 0.004 and 0.04 ± 0.007 vs.
0.02 ± 0.004 and 0.03 ± 0.007 droplets mm_2, respectively.
Plasma metabolite concentrations
Plasma FFA, glycerol, TG, glucose and lactate concentrations
are shown in Fig. 6. Following the onset of exercise, plasma
FFA concentrations increased continuously over time
reaching peak levels 15 min after cessation of exercise.
Thereafter, plasma FFA concentrations declined during
recovery, remaining well above pre-exercise resting levels.
Plasma glycerol concentrations significantly increased
during exercise and immediately decreased following the
cessation of exercise. Plasma TG concentrations gradually
decreased during exercise, and subsequently increased
during recovery. Plasma glucose concentrations showed a
gradual decline with the duration of exercise, with no
significant changes during the recovery period. Within the
first 15 min after the onset of exercise plasma lactate
concentrations had increased well above pre-exercise resting
levels, after which concentrations declined during both the
exercise and recovery stages.
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Figure 4. Substrate source utilisation
during exercise
Substrate utilisation (expressed in kJ min_1)
over time during prolonged submaximal
exercise. Plasma FFA and glucose oxidation
rates significantly increased over time, with
the oxidation rates of other fat sources (sum of
muscle- and lipoprotein-derived TG) and
muscle glycogen being decreased over time
(P < 0.001).
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Correlations
The intramyocellular lipid content in the type I muscle
fibres revealed a positive correlation with the lipid content
in the type II fibres (R = 0.80; P < 0.05). Pre-exercise
intramyocellular lipid content in both the type I and type II
muscle fibres revealed a positive correlation with Wmax
(R = 0.81 and 0.77 respectively; P < 0.05) but not with◊J,max. Pre-exercise IMTG content in the both the type I
and II muscle fibres showed a positive correlation with the
net decrease in intramyocellular lipid content during the
exercise trial. In accordance, the average oxidation rate of
muscle- and lipoprotein-derived TG revealed a significant
positive correlation with pre-exercise IMTG content in the
type I fibres (R = 0.76; P = 0.03). However, the average
oxidation rate of muscle- and lipoprotein-derived TG
during exercise (using stable isotope methodology) did
not correlate with the net decrease in IMTG content in the
type I and/or II muscle fibres (using immunofluorescence
microscopy).
DISCUSSION
The oil red O fluorescence data in the present study
provide convincing evidence that IMTG is rapidly
hydrolysed during moderate intensity exercise in trained
male athletes following an overnight fast. Two hours of
moderate intensity exercise reduced intramyocellular lipid
content by more than 62 ± 7 % in the type I muscle fibres,
whereas no significant changes were observed in the type II
fibres. In addition, on a whole-body level, we show that the
sum of muscle- plus lipoprotein-derived TG oxidation
contributes substantially to total energy expenditure at rest
and during moderate intensity exercise. Furthermore, this
study shows that the oxidation rate of these TG sources
gradually declines with exercise duration, whereas plasma
FFA oxidation rates increase. Together, our data suggest
that IMTG forms an important fuel source for the
exercising muscle in endurance-trained subjects in an
overnight fasted state.
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Figure 5. Intramyocellular lipid content
Mean fibre type-specific intramyocellular lipid content (expressed as percentage of area lipid stained) before
exercise, immediately after exercise and following 2 h of post-exercise recovery as determined by quantitative
fluorescence microscopy on oil red O stained muscle cross-sections (A). Data provided are means ± S.E.M.;
* significantly lower than pre-exercise values; ^ significantly higher than type II muscle fibres (P < 0.05).
Individual results showing average intramyocellular lipid content in the type I muscle fibres before, after and
2 h after exercise (B).
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The present study shows that plasma-derived FFA provide
the majority of fat as a substrate source, with the use of
other fat sources contributing as much as 28 ± 5 and
36 ± 4 % of total fat oxidation at rest and during moderate
intensity exercise, respectively (Table 3 and Fig. 4).
Though these other fat sources have often been assumed to
reflect muscle-derived TG, the applied stable isotope
methodology does not allow differentiation between
muscle- and lipoprotein-derived TG use. At rest, plasma
palmitate Rd by far exceeded Rox (Rox was 36 ± 2 % of Rd;
Table 2). The latter is in accordance with the contention
that a substantial part of plasma FFA uptake is routed
towards re-esterification into IMTG under resting
conditions (van Hall et al. 2002) as well as during exercise
in non-contracting muscle (Sacchetti et al. 2002). In the
present study, we measured plasma [U-13C]palmitate
oxidation rates from the excretion of 13CO2 in the expired
breath. To correct for 13C label retention in the bicarbonate
pool and for incorporation of label into TCA cycle
intermediates, an acetate correction factor was applied
(van Loon et al. 2003a). Omission to apply such a
correction factor would have led to a substantial
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Figure 6. Plasma metabolite concentrations at rest, during prolonged submaximal exercise
and during 2 h of post-exercise recovery
Data provided are means ± S.E.M.; * significant increase over time within the resting, exercise and/or post-
exercise recovery period; ^ significant decrease over time within the resting, exercise and/or post-exercise
recovery period (P < 0.05).
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underestimation of plasma FFA oxidation rates. As the
oxidation of [U-13C]palmitate generates [1,2-13C]acetyl-
CoA, we applied a [1,2-13C]acetate correction factor to
correct for 13C label retention. The latter has been shown to
generate valid and reproducible estimates of plasma
[U-13C]palmitate oxidation rates (Schrauwen et al. 1998).
Trimmer et al. (2001) recently suggested that the use of a
bicarbonate recovery factor would be preferred over an
acetate recovery factor in a study measuring
[1-13C]glucose oxidation rates. Though this suggestion is
unlikely to apply to estimates of [U-13C]palmitate
oxidation, it should be noted that the use of a bicarbonate
recovery factor would have resulted in a slightly lower
estimate of plasma FFA oxidation rate, and therefore an
even larger estimate of IMTG plus lipoprotein TG
oxidation.
During exercise, indirect calorimetry revealed a time-
dependent increase in total fat oxidation rate with a
concomitant decline in total carbohydrate use (Fig. 4). The
observed decrease in total carbohydrate oxidation rate
during exercise was entirely accounted for by a progressive
decrease in muscle glycogen use, whereas the rates of
plasma glucose production (Ra) and utilisation (Rd)
gradually increased (Fig. 3A). Similar shifts in endogenous
carbohydrate source utilisation have been described
before (Romijn et al. 1993; Phillips et al. 1996a). In
accordance with a progressive increase in peripheral
lipolytic rate during prolonged moderate intensity exercise
(Turcotte et al. 1992; Romijn et al. 1993; Phillips et al.
1996a), we observed a substantial increase in palmitate Ra
(Fig. 3) and a concomitant increase in plasma palmitate,
total FFA and glycerol concentrations (Fig. 6) during
exercise. In line with the increase in palmitate Ra, both Rd
and Rox showed similar increases (Fig. 3). After the onset of
exercise the proportion of palmitate Rd that was oxidised
increased substantially, with Rox representing 92 ± 4 % of
Rd during exercise. The latter confirms that muscle
contraction strongly increases the proportion of FFA
uptake that is routed towards oxidation, at the expense of
re-esterification and storage in muscle TG stores
(Sacchetti et al. 2002). Though re-esterification rates of FA
into the IMTG pool are particularly low during exercise
(Guo et al. 2000), it should be noted that minor re-
esterification of labelled palmitate into the IMTG pool,
followed by subsequent lipolysis and oxidation, would
induce a slight overestimation of plasma FFA oxidation
rates and would, therefore, lead to an underestimation of
TG use. The latter implies that these stable isotope
estimates of muscle plus lipoprotein TG oxidation rates
could actually be considered minimal estimates.
The observed increase in plasma FFA oxidation rate
during exercise strongly correlated with the increase in
FFA concentration within each individual subject
(R = 0.88 ± 0.02; P < 0.05). The latter agrees with the
contention that plasma FFA availability forms one of the
factors that determine FFA oxidation during low-to-
moderate intensity exercise (Randle et al. 1963; Romijn et
al. 1995; Dyck et al. 1996). Whereas plasma FFA oxidation
rates substantially increased during exercise, the rate of
muscle- plus lipoprotein-derived TG oxidation declined
during the second hour of exercise, concomitant with the
increase in plasma FFA Ra, Rd and Rox (Fig. 3). These
findings confirm earlier estimations by Romijn et al.
(1993, 1995) and more recent suggestions by Watt et al.
(2002a), and support the contention that a progressive
increase in peripheral lipolytic rate and subsequent
increase in plasma FFA concentrations can suppress
IMTG hydrolysis and its subsequent rate of oxidation.
With hormone-sensitive lipase (HSL; Langfort et al. 1998)
as a likely site at which IMTG hydrolysis and/or oxidation
is regulated, it has been speculated that HSL is not only
stimulated by muscle contraction and increased plasma
adrenaline concentrations (Langfort et al. 1999, 2000) but
may also be inhibited by an increase in intramuscular
long-chain fatty acyl-CoA concentrations, secondary to an
increase in plasma FFA uptake. Indirect evidence for such
a mechanism has been provided by the in vitro observation
that HSL is inhibited in a non-competitive manner by
oleoyl-CoA in bovine adipose tissue (Jepson & Yeaman,
1992). However, other factors such as fibre type-specific
intramyocellular TG depletion could also contribute to the
observed decline in muscle derived TG use during the
latter stages of prolonged exercise (Fig. 5). Clearly, more
research is warranted to investigate the potential
reciprocal relationship between FFA uptake and muscle
TG utilisation. The latter could be clinically relevant, as
elevated FFA concentrations in obese and/or type 2
diabetes patients could be (partly) responsible for their
reduced capacity to utilise muscle- plus lipoprotein-
derived TG during exercise (Blaak et al. 2000; Borghouts et
al. 2002).
In the present study, stable isotope methodology resulted
in an estimated average muscle- plus lipoprotein-derived
TG oxidation rate of 0.22 ± 0.03 g min_1, which
represented a substantial contribution to total energy
expenditure (Table 3 and Fig. 4). As such, our data confirm
earlier reports (Martin et al. 1993; Romijn et al. 1993;
Phillips et al. 1996a; Sidossis et al. 1998; Coyle et al. 2000;
van Loon et al. 2001) and extend their findings by the
observed increase in plasma FFA oxidation rates and the
concomitant decrease in the use of TG sources with the
duration of exercise. However, measurements over the
working limb by Bergman et al. (1999) showed respiratory
quotients (RQ) close to 1.0 during moderate intensity
exercise. Since whole-body respiratory exchange ratios
(RER) values were observed to be lower, Bergman and co-
workers speculated that the majority of fat oxidation
occurs in inactive tissue and that total fat and/or IMTG
oxidation in active muscle is minimal. However, in the
IMTG use during exerciseJ Physiol 553.2 621
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present study, whole-body fat oxidation rates were shown
to increase ~7-fold from rest to exercise, which is unlikely
to be explained by an increase in inactive tissue fat use. In
addition, the observed net reduction in lipid content in the
active vastus lateralis muscle also argues against this
suggestion. The apparent discrepancy is likely to be
explained by the fact that Bergman et al. (1999) tested
subjects after receiving a standardised breakfast, whereas
in the present study subjects were studied after an
overnight fast. In addition, Bergman et al. (1999) studied
untrained subjects before and after 9 weeks of endurance
training, whereas in the present study trained cyclists with
a training history of over 5 years were included. Such
differences are likely to explain the much lower RER values
reported in the present study compared with those
reported by Bergman et al. (1990) (Table 1). In
accordance, other studies measuring FA oxidation over
the working leg have reported much lower values for leg
RQ as well as RER during exercise at similar workloads
(see van Hall et al. 1999). Recent data by van Hall et al.
(2002) show considerable FA oxidation rates over the
working leg during 2 h of one-leg knee-extensor exercise at
65 % of maximal power output. In line with our
observations, they reported 68 % of total fat oxidation over
the leg accounted for by plasma FFA oxidation during the
first 30–60 min of exercise, leaving a considerable
contribution for the use of other fat sources.
Though most stable isotope studies suggest that IMTG-
and/or lipoprotein-derived TG can be used as a substrate
source during prolonged moderate intensity exercise,
studies measuring net changes in muscle TG content by
applying muscle TG extraction analysis on muscle samples
collected before and after exercise have reported
contradicting findings (Watt et al. 2002b). Whereas several
studies have reported a significant net decrease in muscle
TG content following prolonged exercise (Carlson et al.
1971; Froberg & Mossfeldt, 1971; Bergstrom et al. 1973;
Essen et al. 1977; Hurley et al. 1986; Cleroux et al. 1989;
Phillips et al. 1996b; Sacchetti et al. 2002; Watt et al. 2002a)
others did not observe such a decline (Kiens et al. 1993;
Wendling et al. 1996; Starling et al. 1997; Kiens & Richter,
1998; Bergman et al. 1999; Guo et al. 2000). In addition,
others have reported a significant decline in IMTG content
after prolonged exercise in female but not in male subjects
(Roepstorff et al. 2002; Steffensen et al. 2002). This
apparent discrepancy in the literature according to Watt et
al. (2002b) can be explained by the high between-biopsy
variability in muscle TG content when using the
biochemical TG extraction method. The latter could be
caused by large differences in the amount of
extramyocellular fat and/or fibre type composition of the
muscle samples (Wendling et al. 1996; Watt et al. 2002a).
Studies applying MRS to quantify both extra- and
intramyocellular TG content have all reported significant
(~20–40 %) decreases in mixed muscle IMTG content
following prolonged endurance exercise in both trained
men and women (Boesch et al. 1997, 1999; Krssak et al.
2000; Rico-Sanz et al. 2000; Brechtel et al. 2001; Decombaz
et al. 2001; Larson-Meyer et al. 2002; van Loon et al.
2003b).
Both the TG extraction method and the use of MRS are
restricted to the quantification of muscle TG content in
mixed muscle samples and do not differentiate for fibre-
type specific IMTG content. As muscle fibre type
recruitment during endurance type exercise tasks
predominantly relies on the use of type I muscle fibres
(Hultman, 1995), potential net changes in IMTG content
following exercise were hypothesised to be most
predominant in the type I fibres. Therefore, in the present
study, oil red O staining of muscle cross-sections in
combination with (immuno)fluorescence microscopy
(Koopman et al. 2001) was applied to enable selective
quantification of type I and type II muscle fibre lipid
content. Though we recently showed a good correlation
between IMTG content as determined by MRS and
fluorescence microscopy (van Loon et al. 2003b), the latter
technique does not eliminate the problems associated with
the heterogeneity of repeat muscle biopsy samples
(Wendling et al. 1996; Watt et al. 2002a). Nonetheless,
methodological limitations of the TG extraction method,
due to contamination of muscle biopsy samples with
extramyocellular fat and/or differences in muscle fibre-
type content, are excluded. We observed a ~3-fold greater
lipid content in the type I vs. type II muscle fibres (Figs 1
and 5), which is in agreement with others reporting similar
findings following fibre type-specific quantification of
lipid content by biochemical TG extraction (Essen et al.
1975) as well as histochemical oil red O staining using
conventional light microscopy (Malenfant et al. 2001). In
line with the hypothesis that IMTG depletion would be
most pronounced in the type I fibres, we observed a
62 ± 7 % net reduction in lipid content in the type I muscle
fibres after exercise (Fig. 5). This observed decline in
intramyocellular lipid content was accounted for by a
decrease in lipid droplet size as well as droplet density.
Assuming the average IMTG content to range between
3–6 mmol (kg wet muscle)_1 (Guo, 2001), the observed
62 % decline in type I muscle fibre lipid content represents
a TG consumption between 1.5 and 3.0 mmol
(kg mixed muscle)_1. The latter seems in accordance with
the observed average TG oxidation rate of 0.22 ± 0.03 g
min_1, which would translate into an average reduction of
~1.8 mmol TG (kg mixed muscle)_1 over the entire exercise
trial (assuming active muscle mass ~15 kg).
Interestingly, pre-exercise intramyocellular lipid content
in both the type I and type II fibres showed a significant
correlation with individual Wmax. Though the latter is not
the best indicator of endurance training status, these
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findings agree with the contention that endurance training
enhances skeletal muscle lipid storage and/or utilisation
(Hoppeler et al. 1985; Martin et al. 1993; Phillips et al.
1996a; Goodpaster et al. 2001). The latter is substantiated
by the observation that net intramyocellular lipid
depletion (fluorescence microscopy) and the average
IMTG plus lipoprotein TG oxidation rate (stable isotope
methodology) both correlated with pre-exercise
intramyocellular lipid content. This implies that in
endurance-trained athletes the capacity to utilise IMTG is
indeed linked with increased IMTG storage. We did not
observe a significant correlation between the net decline in
intramyocellular lipid content (in the type I and/or type II
fibres) and the IMTG- plus lipoprotein-derived TG
oxidation rate. The latter is not surprising, as the local
decline in absolute muscle lipid content in the vastus
lateralis is unlikely to represent whole-body TG oxidation.
Besides large inter-individual differences in contracting
muscle mass and muscle recruitment, substantial
differences in IMTG content and fat oxidative capacity
have also been reported between various muscle groups
(Boesch et al. 1999; Hwang et al. 2001). Furthermore, a
substantial use of lipoprotein-derived TG could also
contribute to the absence of such a direct correlation.
It has been suggested that IMTG stores could play an
important role as a preferred substrate source during post-
exercise recovery in male subjects (Kiens et al. 1993, 1998).
We did not observe a net change in intramyocellular lipid
content in the type I or type II muscle fibres following 2 h
of post-exercise recovery (Fig. 5). As we did not continue
isotope infusion during recovery, we can only assume that
the increased total fat oxidation rate during post-exercise
recovery period is accounted for by increased plasma FFA
oxidation rate secondary to the increase in plasma FFA
concentration when compared to pre-exercise resting
conditions (Fig. 6). The latter would be in accordance with
van Hall et al. (2002) who observed a substantial increase
in total fat oxidation during recovery from exercise, which
was entirely accounted for by an increase in plasma FFA
oxidation.
In conclusion, the present study shows that prolonged
moderate intensity exercise substantially reduces
intramyocellular lipid content in the type I muscle fibres of
endurance trained male athletes following an overnight
fast. On a whole-body level, we show that the sum of
muscle- and lipoprotein-derived TG oxidation
contributes substantially to total energy expenditure both
at rest and during prolonged exercise. The oxidation rate
of these TG sources declines in the second hour of exercise,
whereas plasma FFA oxidation rate increases in time.
Combined these data suggest that IMTG forms an
important fuel source for the exercising muscle in
endurance-trained subjects in an overnight fasted state.
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